Promore Pharma AB's total assets for Q2 2022 were $31.26M, a decrease of -19.09% from the previous quarter. DE:8T00 total liabilities were $5.16M for the fiscal quarter, a -19.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.